{{Drugbox
| verifiedrevid = 462258957
| IUPAC_name = 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4''H''-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid
| image = Nedocromil.svg
| alt = Structural formula of nedocromil
| image2 = Nedocromil 3D spacefill.png
| alt2 = Space-filling model of the nedocromil molecule
<!--Clinical data-->
| tradename = Alocril
| Drugs.com = {{drugs.com|monograph|alocril-eent}}
| MedlinePlus = a601243
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_CA = <!--                             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = [[inhaler|Inhalation]] and [[eye drops]]
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = 89%
| metabolism = not metabolized
| elimination_half-life = ~3.3 hours
| excretion = excreted unchanged
<!--Identifiers-->
| IUPHAR_ligand = 7607
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 69049-73-6
| ATC_prefix = R01
| ATC_suffix = AC07
| ATC_supplemental =  {{ATC|R03|BC03}}, {{ATC|S01|GX04}}
| PubChem = 50294
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00716
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 45608
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0B535E0BN0
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D05129
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 7492
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 746
<!--Chemical data-->
| C=19 | H=17 | N=1 | O=7
| molecular_weight = 371.341 g/mol
| smiles = O=C\1c3c(N(/C(C(=O)O)=C/1)CC)c(c2O/C(=C\C(=O)c2c3)C(=O)O)CCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = RQTOOFIXOKYGAN-UHFFFAOYSA-N
}}
'''Nedocromil sodium''' is a [[medication]] considered as mast cell stabilizer which act to prevent wheezing, shortness of breath, and other breathing problems caused by [[asthma]]. It is administered by an [[inhaler]] under the brand name '''Tilade''' (although its effects in this form are far less than those in [[albuterol]] or other well-known [[inhaler]] medications) and as an [[eye drop]] under the brand name '''Alocril'''.<ref>{{cite web|title=ALOCRIL Product Information|url=http://www.allergan.com/products/eye_care/alocril.htm|publisher=ALLERGAN|accessdate=17 May 2013}}</ref><ref>{{cite web|title=ALOCRIL (nedocromil sodium) solution/ drops|url=http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fe8d7ad-2158-4169-94b0-719ad20242b7|publisher=NIH|accessdate=17 May 2013}}</ref>  Liquid preparations are available in the [[UK]] under the name '''Rapitil''' for use for allergic eye reactions.<ref>{{cite web|url=http://www.patient.co.uk/showdoc/30003772|title=Nedocromil eye drops|date=2007-02-02|accessdate=2009-08-04}}</ref> Nedocromil sodium has been shown to be effective in alleviating symptoms of [[allergic conjunctivitis]].<ref name="Castillo">{{cite journal |authors=Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A |title= Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis |journal=Cochrane Database Syst Rev|volume=6 |pages= CD009566 |date=2015 |pmid= 26028608 |doi= 10.1002/14651858.CD009566.pub2}}</ref> 

Nedocromil is classified as a [[Chromone|benzopyrone]].  Nedocromil acts as a [[mast cell stabilizer]], inhibits the degranulation of [[mast cell]]s, prevents release of [[histamine]] and [[tryptase]], so preventing the synthesis of [[prostaglandin]]s and [[leukotriene]]s.  US Production of inhaled nedocromil ceased in April 2008.<ref>{{cite web|url=http://www.fda.gov/drugs/drugsafety/drugsafetypodcasts/ucm209072.htm|title=Questions and Answers:Phase-Out of CFC Metered-Dose Inhalers Containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil|publisher=|accessdate=18 September 2014}}</ref>

==References==
{{commonscatinline}}
{{reflist}}

{{Nasal preparations}}
{{Asthma and copd rx}}
[[Category:Mast cell stabilizers]]
[[Category:Ophthalmology drugs]]
[[Category:Dicarboxylic acids]]
[[Category:Nitrogen heterocycles]]
[[Category:Oxygen heterocycles]]
[[Category:Heterocyclic compounds (3 rings)]]
[[Category:Diketones]]

{{respiratory-system-drug-stub}}